BC Week In Review | Dec 16, 2016
Clinical News

Dasiglucagon in a dual-hormone artificial pancreas system: Ph IIa start

Zealand began an open-label, crossover, U.S. Phase IIa trial to compare dasiglucagon in a dual-hormone artificial pancreas system vs. glucagon in 1-day periods in up to 20 patients. Earlier this year, Beta Bionics Inc. (Boston,...
Items per page:
1 - 1 of 1